Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-011455-51Phase 2Terminated
Phase 2, randomised, open-label trial of bleomycin in cutaneous metastases and Non-hematologic malignancy (2 arms), sponsored by Department of Oncology, Herlev University Hospital. Primary endpoint: Response rate. Started Apr 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-011455-51.